Zdrowie i gospodarka · 27/10/2000

FDA Releases Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products

The Food and Drug Administration (FDA) has made available a guidance document outlining general considerations for bioavailability and bioequivalence studies for orally administered drug products, aiming to simplify the process for pharmaceutical sponsors and applicants.